Systematic MicroRNA Analysis Identifies ATP6V0C as an Essential Host Factor for Human Cytomegalovirus Replication

English version České info

Recent advances in microRNA target identification have greatly increased the number of putative targets of viral microRNAs. However, it is still unclear whether all targets identified are biologically relevant. Here, we use a combined approach of RISC immunoprecipitation and focused siRNA screening to identify targets of HCMV encoded human cytomegalovirus that play an important role in the biology of the virus. Using both a laboratory and clinical strain of human cytomegalovirus, we identify over 200 putative targets of human cytomegalovirus microRNAs following infection of fibroblast cells. By comparing RISC-IP profiles of miRNA knockout viruses, we have resolved specific interactions between human cytomegalovirus miRNAs and the top candidate target transcripts and validated regulation by western blot analysis and luciferase assay. Crucially we demonstrate that miRNA target genes play important roles in the biology of human cytomegalovirus as siRNA knockdown results in marked effects on virus replication. The most striking phenotype followed knockdown of the top target ATP6V0C, which is required for endosomal acidification. siRNA knockdown of ATP6V0C resulted in almost complete loss of infectious virus production, suggesting that an HCMV microRNA targets a crucial cellular factor required for virus replication. This study greatly increases the number of identified targets of human cytomegalovirus microRNAs and demonstrates the effective use of combined miRNA target identification and focused siRNA screening for identifying novel host virus interactions.

Vyšlo v časopise: Systematic MicroRNA Analysis Identifies ATP6V0C as an Essential Host Factor for Human Cytomegalovirus Replication. PLoS Pathog 9(12): e32767. doi:10.1371/journal.ppat.1003820
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003820

Souhrn

Zdroje

1. NelsonJA, GnannJWJr, GhazalP (1990) Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol 154: 75–100.

2. BoehlerA, SchaffnerA, SalomonF, KeuschG (1994) Cytomegalovirus disease of late onset following renal transplantation: a potentially fatal entity. Scand J Infect Dis 26: 369–373.

3. BallardRA, DrewWL, HufnagleKG, RiedelPA (1979) Acquired cytomegalovirus infection in preterm infants. Am J Dis Child 133: 482–485.

4. AdlerSP (1983) Transfusion-associated cytomegalovirus infections. Rev Infect Dis 5: 977–993.

5. EinhornL, OstA (1984) Cytomegalovirus infection of human blood cells. J Infect Dis 149: 207–214.

6. MacherAM, ReichertCM, StrausSE, LongoDL, ParrilloJ, et al. (1983) Death in the AIDS patient: role of cytomegalovirus. N Engl J Med 309: 1454.

7. NeimanP, WassermanPB, WentworthBB, KaoGF, LernerKG, et al. (1973) Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 15: 478–485.

8. TegtmeierGE (1988) The use of cytomegalovirus-screened blood in neonates. Transfusion 28: 201–203.

9. LarssonS, Soderberg-NauclerC, WangFZ, MollerE (1998) Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 38: 271–278.

10. Soderberg-NauclerC, FishKN, NelsonJA (1997) Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91: 119–126.

11. StanierP, KitchenAD, TaylorDL, TymsAS (1992) Detection of human cytomegalovirus in peripheral mononuclear cells and urine samples using PCR. Mol Cell Probes 6: 51–58.

12. Taylor-WiedemanJ, SissonsJG, BorysiewiczLK, SinclairJH (1991) Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72 (Pt 9) 2059–2064.

13. MyersonD, HackmanRC, NelsonJA, WardDC, McDougallJK (1984) Widespread presence of histologically occult cytomegalovirus. Hum Pathol 15: 430–439.

14. GoodrumF, CavinessK, ZagalloP (2012) Human cytomegalovirus persistence. Cell Microbiol 14: 644–655.

15. GrundhoffA, SullivanCS (2011) Virus-encoded microRNAs. Virology 411: 325–343.

16. DunnW, TrangP, ZhongQ, YangE, van BelleC, et al. (2005) Human cytomegalovirus expresses novel microRNAs during productive viral infection. Cell Microbiol 7: 1684–1695.

17. GreyF, AntoniewiczA, AllenE, SaugstadJ, McSheaA, et al. (2005) Identification and characterization of human cytomegalovirus-encoded microRNAs. J Virol 79: 12095–12099.

18. MesheshaMK, Veksler-LublinskyI, IsakovO, ReichensteinI, ShomronN, et al. (2012) The microRNA Transcriptome of Human Cytomegalovirus (HCMV). Open Virol J 6: 38–48.

19. PfefferS, SewerA, Lagos-QuintanaM, SheridanR, SanderC, et al. (2005) Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269–276.

20. StarkTJ, ArnoldJD, SpectorDH, YeoGW (2012) High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection. J Virol 86: 226–235.

21. TuddenhamL, PfefferS (2011) Roles and regulation of microRNAs in cytomegalovirus infection. Biochim Biophys Acta 1809: 613–622.

22. GreyF, MeyersH, WhiteEA, SpectorDH, NelsonJ (2007) A Human Cytomegalovirus-Encoded microRNA Regulates Expression of Multiple Viral Genes Involved in Replication. PLoS Pathog 3: e163.

23. BellareP, GanemD (2009) Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6: 570–575.

24. LeiX, BaiZ, YeF, XieJ, KimCG, et al. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat Cell Biol 12: 193–199.

25. LuF, StedmanW, YousefM, RenneR, LiebermanPM (2010) Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol 84: 2697–2706.

26. MurphyE, VanicekJ, RobinsH, ShenkT, LevineAJ (2008) Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc Natl Acad Sci U S A 105: 5453–5458.

27. Stern-GinossarN, ElefantN, ZimmermannA, WolfDG, SalehN, et al. (2007) Host immune system gene targeting by a viral miRNA. Science 317: 376–381.

28. KarginovFV, ConacoC, XuanZ, SchmidtBH, ParkerJS, et al. (2007) A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci U S A 104: 19291–19296.

29. GreyF, TirabassiR, MeyersH, WuG, McWeeneyS, et al. (2010) A viral microRNA down-regulates multiple cell cycle genes through mRNA 5′UTRs. PLoS Pathog 6: e1000967.

30. DolkenL, MaltererG, ErhardF, KotheS, FriedelCC, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7: 324–334.

31. FarhKK, GrimsonA, JanC, LewisBP, JohnstonWK, et al. (2005) The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science 310: 1817–1821.

32. LewisBP, BurgeCB, BartelDP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.

33. LimLP, LauNC, Garrett-EngeleP, GrimsonA, SchelterJM, et al. (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769–773.

34. LimJH, ParkJW, KimSJ, KimMS, ParkSK, et al. (2007) ATP6V0C competes with von Hippel-Lindau protein in hypoxia-inducible factor 1alpha (HIF-1alpha) binding and mediates HIF-1alpha expression by bafilomycin A1. Mol Pharmacol 71: 942–948.

35. GottweinE, CorcoranDL, MukherjeeN, SkalskyRL, HafnerM, et al. (2011) Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe 10: 515–526.

36. HaeckerI, GayLA, YangY, HuJ, MorseAM, et al. (2012) Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog 8: e1002884.

37. RileyKJ, RabinowitzGS, YarioTA, LunaJM, DarnellRB, et al. (2012) EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31: 2207–2221.

38. SkalskyRL, CorcoranDL, GottweinE, FrankCL, KangD, et al. (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8: e1002484.

39. KimY, LeeS, KimS, KimD, AhnJH, et al. (2012) Human cytomegalovirus clinical strain-specific microRNA miR-UL148D targets the human chemokine RANTES during infection. PLoS Pathog 8: e1002577.

40. LeeSH, KalejtaRF, KerryJ, SemmesOJ, O'ConnorCM, et al. (2012) BclAF1 restriction factor is neutralized by proteasomal degradation and microRNA repression during human cytomegalovirus infection. Proc Natl Acad Sci U S A 109: 9575–9580.

41. ForgacM (2007) Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917–929.

42. RyckmanBJ, JarvisMA, DrummondDD, NelsonJA, JohnsonDC (2006) Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J Virol 80: 710–722.

43. SanchezV, GreisKD, SztulE, BrittWJ (2000) Accumulation of virion tegument and envelope proteins in a stable cytoplasmic compartment during human cytomegalovirus replication: characterization of a potential site of virus assembly. J Virol 74: 975–986.

44. Stern-GinossarN, SalehN, GoldbergMD, PrichardM, WolfDG, et al. (2009) Analysis of human cytomegalovirus-encoded microRNA activity during infection. J Virol 83: 10684–10693.

45. BenarochP, YillaM, RaposoG, ItoK, MiwaK, et al. (1995) How MHC class II molecules reach the endocytic pathway. EMBO J 14: 37–49.

46. MacfarlaneDE, ManzelL (1998) Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J Immunol 160: 1122–1131.

47. UmashankarM, PetrucelliA, CicchiniL, CaposioP, KreklywichCN, et al. (2011) A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog 7: e1002444.

48. EasowG, TelemanAA, CohenSM (2007) Isolation of microRNA targets by miRNP immunopurification. Rna 13: 1198–1204.

49. RehmsmeierM, SteffenP, HochsmannM, GiegerichR (2004) Fast and effective prediction of microRNA/target duplexes. Rna 10: 1507–1517.

50. RueCA, JarvisMA, KnocheAJ, MeyersHL, DeFilippisVR, et al. (2004) A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. J Virol 78: 12529–12536.